BMS and RCUS Related Headlines
Go Back- Arcus Biosciences partners with Bristol Myers Squibb on kidney cancer trial
- Arcus Biosciences Announces Clinical Trial Collaboration and Supply Agreement to Evaluate Casdatifan in Combination with PD‑L1/VEGF‑A Bispecific Immunomodulator to Treat Kidney Cancer

